True Wealth Design
RYTM icon

True Wealth Design’s Rhythm Pharmaceuticals RYTM Stock Holding History

True Wealth Design’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14K Hold
147
– – ﹤0.01% 945
2026
Q2 		$16.3K Hold
147
– – ﹤0.01% 889
2026
Q1 		$12.8K Hold
147
– – ﹤0.01% 894
2025
Q4 		$15.7K Hold
147
– – ﹤0.01% 685
2025
Q3 		$14.8K Hold
147
– – ﹤0.01% 706
2025
Q2 		$9.29K Buy
147
+90
+158% +$5.51K ﹤0.01% 610
2025
Q1 		$3.02K Buy
+57
New +$3.16K ﹤0.01% 857

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Fulton Bank
Fulton Bank Lancaster, Pennsylvania $3.29B AUM 13.65% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Elevation Wealth Partners
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

True Wealth Design's RYTM Position: Q3 2026 in Review

True Wealth Design held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 147 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

True Wealth Design first reported a position in RYTM in Q1 2025 and has held it in 7 quarters since. The position peaked at $16.3K in Q2 2026. 28 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • True Wealth Design held 147 shares of Rhythm Pharmaceuticals worth $14K as of Q3 2026.
  • True Wealth Design left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #945 holding.
  • True Wealth Design first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Rhythm Pharmaceuticals position peaked at $16.3K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.